Navigation Links
Alimera Sciences Reports Fourth Quarter 2012 Financial Results
Date:3/21/2013

0;million for the fourth quarter of 2011. The increase was primarily attributable to the preparation for the planned launch of ILUVIEN in Europe in 2013.

Net loss for the fourth quarter ended December 31, 2012 was $5.3 million, or $(0.17) per common share, compared with a net loss of $6.1 million, or $(0.19) per common share, for the quarter ended December 31, 2011. Net loss per share was based on 31,524,004 weighted average shares outstanding for the fourth quarter of 2012 and 31,421,395 weighted average shares outstanding for the fourth quarter of 2011. 

As of December 31, 2012, Alimera had cash, cash equivalents and investments of $49.6 million, compared to $33.6 million as of December 31, 2011.  

Conference Call to be Held TodayAlimera will hold a conference call today at 4:30 PM ET to discuss these results and provide regulatory and commercial updates.  The conference call will be hosted by Dan Myers , president and chief executive officer, and Rick Eiswirth , chief operating officer and chief financial officer.

To participate in the call, please dial (877) 369-6586 (U.S. and Canada) or (253) 237-1165 (international). A live webcast will be available on the Investor Relations section of the corporate website at www.alimerasciences.com.

A replay of the conference call will be available beginning March 21, 2013 at 7:30 P.M. ET and ending on March 28, 2013 by dialing (855) 859-2056 (U.S. and Canada) or (404) 537-3406 (international), Conference ID Number: 19269391. A replay of the webcast will be available on the corporate website for one week, through March 28, 2013.

About Alimera Sciences, Inc.Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company th
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alimera Sciences To Release Fourth Quarter And Fiscal Year 2012 Financial Results
2. Alimera Sciences Participating in Credit Suisse London One-on-One Healthcare Conference
3. Alimera Sciences Names European Management Team
4. Alimera Sciences To Present At Credit Suisse 2012 Healthcare Conference
5. Alimera Sciences To Present At 2012 Stifel Nicolaus Healthcare Conference
6. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2012 Annual Report
7. BioDelivery Sciences to Present at the 25th Annual ROTH Conference
8. Industry Veteran Katrine Bosley Joins Genocea Biosciences Board Of Directors
9. Pressure BioSciences, Inc. to Present at the SeeThruEquity Spring Investor Microcap Forum
10. Neurocrine Biosciences To Present At The 25th Annual Roth Conference
11. PointCross Life Sciences SENDBox and SEND-as-a-Service Prepare Pharma Companies to Comply with the FDAs Upcoming e-Data Submission Mandate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage ... pain, announced today that it has appointed Mr. ... Director of Clinical Development. During his extensive ... led successful global clinical operations teams, in the US ... clinical development of numerous therapeutics and diagnostics across a ...
(Date:9/18/2014)... Nev. and ROCKVILLE, Md. ... SPPI ), a biotechnology company with fully ... focus in hematology and oncology, and CASI Pharmaceuticals, Inc. ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a primary focus on ...
(Date:9/18/2014)... , September 18, 2014 ... economic growth, and the situation is most likely to deteriorate ... is observing an impact across all sectors in the form ... rise in inflation, limited access to external financing and international ... could experience an increase in payment delays and defaults. ...
Breaking Medicine Technology:Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development 2Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 2Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 3Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 4Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 5Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 6Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 7Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 8Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 9Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 10Exporters to Russia Facing Increasing Payment Risk 2
... SeQual Technologies, Inc., a pioneer in portable oxygen technology, ... by Chart Industries, wholly owned subsidiary, CAIRE Inc., a ... care market. SeQual has built a strong reputation based ... a leader in portable oxygen concentrators, SeQual will complement ...
... SRI International, an independent nonprofit research and ... with PhenoMatriX (PMX), a biotechnology company, on the ... cisplatin and related analogues are used to treat ... major weapons against solid tumors and other difficult-to-treat ...
Cached Medicine Technology:SeQual Technologies to be Acquired by Chart Industries 2SRI International and PhenoMatriX Collaborate to Develop Platin-Based Chemotherapies 2SRI International and PhenoMatriX Collaborate to Develop Platin-Based Chemotherapies 3SRI International and PhenoMatriX Collaborate to Develop Platin-Based Chemotherapies 4
(Date:9/18/2014)... (PRWEB) September 18, 2014 ItsHot.com, a ... is now offering a 65-80% discount on its attractive ... whopping 71% off on its 14K Gold Pave Diamond ... band can now be bought for just $775. The ... , Talking about this diamond band, a representative stated, ...
(Date:9/18/2014)... City, UT & Baltimore, MD (PRWEB) September 18, 2014 ... its founder, Frank Davis, are pleased to announce the ... whole-food powder made from the nutrient-rich liquid of young, ... the newest product in the highly-acclaimed Activz Whole-Food Nutrition ... of organic fruit, vegetable and grass options. The ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Throughout their ... cheer each other on, celebrate their achievements and accomplishments ... laughter, heartache and joy. , Joanie’s Sisters in Support, ... for women joined together by their battles against breast ... The group, which was organized in June, meets once ...
(Date:9/18/2014)... understanding the nature of the fight for superiority between ... therapies to combat leukaemia, say researchers from the University ... in Cell Reports , investigated Acute Myeloid Leukaemia ... develop normally into mature blood cells. , Stem cells ... cells each day. The process resembles a production line ...
(Date:9/18/2014)... independent groups of researchers led by Sidney (Wally) ... Charles Lowenstein, MD, of the University of Rochester, ... a gene called STXBP5 plays in the development ... genome-wide association studies (GWAS) identified a gene called ... called Von Willebrand factor (VWF). , VWF is ...
Breaking Medicine News(10 mins):Health News:ItsHot.com Now Offering 65-80% Discount on its Striking Collection of Diamond Wedding Bands 2Health News:New Activz Organic Coconut Water Powder Announced at Natural Products Expo East 2Health News:New Activz Organic Coconut Water Powder Announced at Natural Products Expo East 3Health News:Artist’s Cancer Jewelry to Benefit Joanie’s Sisters 2Health News:Artist’s Cancer Jewelry to Benefit Joanie’s Sisters 3Health News:The war on leukemia: How the battle for cell production could be decisive 2Health News:University of Kentucky research explores STXBP5 gene and its role in blood clotting 2
... secret stash of the virus makes it that much harder ... -- Medications can reduce the level of the AIDS virus ... often roars back when patients stop taking their pills. Now, ... manages to hide and avoid the killing powers of medicine. ...
... between stress and death risk, researchers say , SUNDAY, March ... misery and death has helped researchers identify a gene variant ... U.S. research team focused on a gene called IL6, which ... to cardiovascular disease, neurodegeneration and some types of cancer. , ...
... The Pediatric Cancer ... Annual “Reaching for the Cure” 10K Run, 5K Run/Walk, and 1K Kids’ Fun Run ... Irvine, CA (PRWEB) March 7, ... “Reaching for the Cure” Half Marathon | 10K 5K Run | 5K Walk | ...
... ... Khanna Institute of LASIK and Refractive Surgery. , ... (Vocus) March 6, 2010 -- Khanna Institute of LASIK and Refractive ... Baldwin brothers, 43, attended the fundraiser with his daughter and Alec,s daughter Ireland, 14. The ...
... cuff surgery remains significantly different when compared to the ... In the study, researchers used X-rays providing a ... relation to the shoulder blade, to compared motion in ... repair of tendon tears and no symptoms in their ...
... MO - Breast cancer patients with early stage disease that ... from radiation after mastectomy, because of the low present-day risk ... that could one day change the course of treatment for ... The University of Texas M. D. Anderson Cancer. The ...
Cached Medicine News:Health News:HIV Hides Out in Bone Marrow Cells 2Health News:Gene Variant May Help Some Overcome Adversity 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 3Health News:Khanna and Stephen Baldwin Attend Carol M. Baldwin Breast Cancer Research 2Health News:Henry Ford Hospital study: Shoulder function not fully restored after surgery 2Health News:Most early-stage breast cancer patients may not need radiation after mastectomy 2Health News:Most early-stage breast cancer patients may not need radiation after mastectomy 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: